The doctor-recommended treatment killing half of cancer patients within 30 days

The remedy is worse than the disease.

Scholars credit Sir Francis Bacon, the 17th-century English philosopher and “Renaissance Man,” with that keen observation. And after reading through the results of a study published recently in The Lancet Oncology, Bacon’s words seem to warn specifically against one horrific, modern treatment…


For this new study, researchers analyzed mortality rates for all patients living in England in 2014 with breast and lung cancer. They specifically zeroed in on death rates during the first 30 days after the patients began receiving chemotherapy.

Of course, chemotherapy has long been a mainstay in mainstream medicine for treating cancers. Sure, it targets faster-growing cancer cells. But it often misses the cancer “stem” cells—also known as “mother cells.” And these are the cells that can ultimately give life to new cancer tumors.

Chemotherapy also causes collateral damage to GI cells, brain cells, hair follicles, and other normal, healthy cells—accounting for all the awful, standard side effects of this toxic treatment.

So, without further ado, let’s dive right into the details of the Lancet study…

Up to 51 percent of patients died within a month

For the recent study, researchers analyzed data on all the women with breast cancer and all the people with lung cancer in England who began a “cycle” of chemotherapy in 2014. All the patients were 24 years or older. Overall, the study included more than 23,000 women with breast cancer and almost 10,000 men and women with lung cancer.

It turns out, 8.4 percent of lung cancer patients and 2.4 percent of breast cancer patients died within just one month of getting chemotherapy.

Plus, in some hospitals, the 30-day death rates were drastically higher…

In fact, at the world-famous Cambridge University Hospital, 20 percent of women with breast cancer died within just 30 days of beginning chemotherapy treatment. And at another center, 51 percent of men and women with lung cancer died within a month’s time!

A few articles have described the Lancet study as “groundbreaking” because it was the first-ever to examine 30-day death rates associated with chemotherapy. But for me, a better description would be “alarming”…and for two big reasons…

First, I know through my training and work as a Medical Examiner that cancer itself rarely causes “sudden death” within just 30 days of diagnosis. Instead, it progresses slowly…if not stopped.

Of course, lung cancer is particularly brutal. And patients are often given just months to live—but not typically only one month.

When it comes to breast cancer, women (especially older women) often survive 20 years or more after being diagnosed.

So, when a patient dies within 30 days after beginning a chemo regimen, it indicates that the treatment, not the cancer itself, is to blame.

But guess what can be a cause of sudden death—POISON. And chemotherapy is poison. It’s so powerful and so toxic, it can even lead to death within 30 days.

It’s also alarming to me that this is the first study to ever analyze 30-day death rates associated with chemotherapy.

Of course, mainstream medicine has no interest in promoting or funding this kind of analysis. Instead, they want to keep the curtain drawn to hide these horrific statistics and continue lining their pockets.

Chemotherapy is, quite simply, the backbone of the cancer industry, supporting the oncologists who design the treatment plans, the cancer centers that deliver the chemo, the diagnostic centers that administer routine scans, and big pharma itself.

In fact, in 2017 alone, the cancer industry made $133 billion on pharmaceutical approaches to cancer. Some drugs can even cost patients between $100,000 and $500,000 a year. (That is, if they don’t kill you within 30 days.) And a high proportion of them aren’t even curative.

Which brings me to my next point…

So-called “palliative chemo” fast-tracks a patient’s decline

In many cases, chemotherapy can’t cure the cancer. But oncologists still administer it as a “palliative” approach, hoping to shrink or slow the tumor temporarily.

Palliative chemotherapy is a treatment designed for terminal cancer patients to prolong survival and ease symptoms—but not cure the disease.

But this approach can often do the exact opposite and fast-track a patient’s decline…

In fact, the Lancet study found that within 30 days of starting palliative chemotherapy, 28 percent of lung cancer patients at just one major academic medical center in England died.

Let’s put all these findings into perspective…

Failing grades in terms of safety and efficacy

Of all the pharmaceutical drugs on the market, chemotherapy drugs must rank the worst in terms of safety—as they cause horrific, debilitating side effects, including the ultimate “side effect” of death, in up to half of patients.

In terms of efficacy, they frequently don’t work either. So, that presents a really poor therapeutic index.

“Tis more the pity,” as they might say in the U.K., because a host of natural botanical remedies have potent anti-cancer properties that can help people prevent—and even reverse—cancer.

Plus, these natural remedies can differentiate between healthy and cancerous cells—which is huge. In other words, they target cancer cells without destroying normal, healthy cells.

In addition, many botanical remedies can work with chemotherapy, as examples of true “complementary” medicine. Patients who use these botanicals can receive a dramatically reduced dose of chemotherapy, lessening its harmful side effects. And most likely reducing your risk of dying (instead of increasing it) within 30 days of starting it!

You can learn all about the natural, no-nonsense approaches to combatting cancer in my online Authentic Anti-Cancer Protocol. Find out more about it or enroll today by clicking here.

I began this Dispatch with a quote from Sir Francis Bacon. And I’ll close it with another well-known saying that reminds me of chemotherapy…

“The treatment was a success, but the patient died.”

Of course, this study was conducted in England and published in a British journal. So, when will researchers in the U.S. start taking note of the grim statistics?

Unfortunately, I’m not holding my breath. And you shouldn’t either.


“30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.” The Lancet, 2016; 13(9) 1203-1216.

“Global Oncology Trends 2018.” IQVIA™, 5/24/2018. (

Big Pharma’s Go-To Defense of Soaring Drug Prices Doesn’t Add Up.” The Atlantic, 3/23/2019. (